Real-world efficacy and safety of momelotinib for myelofibrosis: evaluation of a UK-wide study VJHemOnc – Video Journal of Hematology & HemOnc 2:37 1 month ago 64 Далее Скачать
Efficacy of momelotinib in thrombocytopenic patients with myelofibrosis from MOMENTUM VJHemOnc – Video Journal of Hematology & HemOnc 3:48 2 years ago 323 Далее Скачать
Indirect comparison of momelotinib vs pacritinib safety and anemia outcomes in myelofibrosis VJHemOnc – Video Journal of Hematology & HemOnc 1:28 1 year ago 131 Далее Скачать
Latest updates on momelotinib: safety, durability of response & survival benefit VJHemOnc – Video Journal of Hematology & HemOnc 3:02 2 years ago 464 Далее Скачать
An insight into the MOMENTUM trial: safety and efficacy of momelotinib for the treatment of MF VJHemOnc – Video Journal of Hematology & HemOnc 3:03 2 years ago 370 Далее Скачать
Safety and anemia outcomes with momelotinib vs pacritinib in patients with myelofibrosis VJHemOnc – Video Journal of Hematology & HemOnc 3:20 1 year ago 335 Далее Скачать
Long-term safety of momelotinib for myelofibrosis VJHemOnc – Video Journal of Hematology & HemOnc 2:16 4 years ago 103 Далее Скачать
Real-world data analysis of ruxolitinib in myelofibrosis VJHemOnc – Video Journal of Hematology & HemOnc 3:09 4 years ago 149 Далее Скачать
The promise of momelotinib in the treatment of myelofibrosis VJHemOnc – Video Journal of Hematology & HemOnc 3:00 2 years ago 628 Далее Скачать
Approved and emerging agents to manage anemia and thrombocytopenia in myelofibrosis VJHemOnc – Video Journal of Hematology & HemOnc 1:49 1 year ago 280 Далее Скачать
Analysis of long-term exposure to momelotinib in the Phase III SIMPLFY myelofibrosis trials VJHemOnc – Video Journal of Hematology & HemOnc 2:07 4 years ago 113 Далее Скачать
One Thousand Patients With Primary Myelofibrosis: the Mayo Clinic Experience Mayo Proceedings 5:14 12 years ago 1 436 Далее Скачать
Momelotinib: a promising drug for patients with myelofibrosis VJHemOnc – Video Journal of Hematology & HemOnc 3:43 2 years ago 858 Далее Скачать
Reviewing the role and efficacy of ruxolitinib in myelofibrosis ten years after its approval VJHemOnc – Video Journal of Hematology & HemOnc 1:15 1 year ago 259 Далее Скачать
FDA Approves JAK Inhibitor Momelotinib for Myelofibrosis in Anemic Adults Medical Dialogues 2:25 1 year ago 242 Далее Скачать
Glofitamab and epcoritamab in the real-world setting: a UK multi-center retrospective analysis VJHemOnc – Video Journal of Hematology & HemOnc 2:18 2 days ago 32 Далее Скачать
MAIC of momelotinib versus fedratinib safety in myelofibrosis VJHemOnc – Video Journal of Hematology & HemOnc 1:52 1 year ago 78 Далее Скачать
Indirect Treatment Comparison Shows Momelotinib Has ‘Favorable’ Safety in Myelofibrosis Blood Cancers Today 5:25 1 year ago 105 Далее Скачать
The current research on momelotinib for myelofibrosis VJHemOnc – Video Journal of Hematology & HemOnc 2:07 8 years ago 382 Далее Скачать
